As of 2026-03-30, the EV/EBITDA ratio of Ramm Pharma Corp (RAMM.CN) is -0.58. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. RAMM.CN's latest enterprise value is 1.66 mil CAD. RAMM.CN's TTM EBITDA according to its financial statements is -2.86 mil CAD. Dividing these 2 quantities gives us the above RAMM.CN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 2.1x - 5.8x | 3.5x |
| Forward P/E multiples | 0.5x - 1.5x | 0.7x |
| Fair Price | (0.03) - (0.02) | (0.03) |
| Upside | -325.7% - -249.1% | -320.9% |
| Date | EV/EBITDA |
| 2026-03-20 | -0.58 |
| 2026-03-18 | -0.58 |
| 2026-03-09 | -0.58 |
| 2026-03-04 | -0.86 |
| 2026-02-27 | -0.86 |
| 2026-02-23 | -1.14 |
| 2026-02-19 | -0.86 |
| 2026-02-17 | -1.14 |
| 2026-02-10 | -1.14 |
| 2026-02-09 | -1.14 |
| 2026-02-05 | -1.42 |
| 2026-02-04 | -1.70 |
| 2026-02-03 | -1.70 |
| 2026-01-28 | -1.42 |
| 2026-01-19 | -1.70 |
| 2026-01-14 | -1.98 |
| 2026-01-12 | -1.98 |
| 2026-01-05 | -1.98 |
| 2025-12-31 | -3.09 |
| 2025-12-30 | -2.81 |
| 2025-12-29 | -2.53 |